Jeffrey T. Walsh
2019
In 2019, Jeffrey T. Walsh earned a total compensation of $5.3M as Former Chief Strategy Officer at bluebird bio, a 43% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $206,213 |
---|---|
Option Awards | $2,935,690 |
Salary | $470,000 |
Stock Awards | $1,136,008 |
Other | $510,246 |
Total | $5,258,157 |
Walsh received $2.9M in option awards, accounting for 56% of the total pay in 2019.
Walsh also received $206.2K in non-equity incentive plan, $470K in salary, $1.1M in stock awards and $510.2K in other compensation.
Rankings
In 2019, Jeffrey T. Walsh's compensation ranked 2,058th out of 13,971 executives tracked by ExecPay. In other words, Walsh earned more than 85.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,058 out of 13,971 | 85th |
Division Manufacturing | 748 out of 5,701 | 87th |
Major group Chemicals And Allied Products | 226 out of 2,200 | 90th |
Industry group Drugs | 183 out of 1,886 | 90th |
Industry Biological Products, Except Diagnostic Substances | 47 out of 389 | 88th |
Source: SEC filing on April 27, 2020.
Walsh's colleagues
We found five more compensation records of executives who worked with Jeffrey T. Walsh at bluebird bio in 2019.